Secondary hyperparathyroidism: pathogenesis and latest treatment

M Mizobuchi, H Ogata, F Koiwa - Therapeutic Apheresis and …, 2019 - Wiley Online Library
The classic pathogenesis of secondary hyperparathyroidism (SHPT) began with the trade‐
off hypothesis based on parathyroid hormone hypersecretion brought about by renal failure …
被引用次数：96 相关文章

Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment

M Mizobuchi, H Ogata, F Koiwa - … apheresis and dialysis …, 2019 - pubmed.ncbi.nlm.nih.gov
The classic pathogenesis of secondary hyperparathyroidism (SHPT) began with the trade-off
hypothesis based on parathyroid hormone hypersecretion brought about by renal failure …

Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment.

M Mizobuchi, H Ogata, F Koiwa - Therapeutic Apheresis & …, 2019 - search.ebscohost.com
The classic pathogenesis of secondary hyperparathyroidism (SHPT) began with the trade‐
off hypothesis based on parathyroid hormone hypersecretion brought about by renal failure …

Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment

M Mizobuchi, H Ogata, F Koiwa - Therapeutic Apheresis and Dialysis, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The classic pathogenesis of secondary
hyperparathyroidism (SHPT) began with the trade‐off hypothesis based on parathyroid …

Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment.

M Mizobuchi, H Ogata, F Koiwa - Therapeutic Apheresis and …, 2018 - europepmc.org
The classic pathogenesis of secondary hyperparathyroidism (SHPT) began with the trade-off
hypothesis based on parathyroid hormone hypersecretion brought about by renal failure …